No items found.
GoodRx's entry into the GLP-1 telehealth space brings the trust and scale of America's leading prescription savings platform to weight loss care. Launched in November 2025, GoodRx for Weight Loss takes a deliberately different approach from competitors: FDA-approved medications only, no compounded alternatives. Their partnership with Novo Nordisk delivers genuinely competitive cash pricing on Ozempic, Wegovy, and the new oral semaglutide pill, and access to over 70,000 pharmacies gives unmatched flexibility for prescription fulfillment.
The brand trust factor is enormous — nearly 30 million Americans already use GoodRx for prescription savings, and over one million healthcare professionals rely on the platform. The Novo Nordisk partnership delivers tangible value with oral semaglutide pricing from $149/month and injectable pricing from $199-$349/month, competitive with or below many compounded alternatives while offering the safety assurance of FDA-approved products. The pharmacy network is a standout advantage: fill your prescription at any of 70,000+ participating pharmacies or get home delivery, giving flexibility no compounded-only provider can match. The focus on FDA-approved medications means patients get drugs with established safety profiles, consistent manufacturing standards, and proven clinical trial data.
The $119/month subscription fee on top of medication costs makes the total price higher than many competitors, especially for patients on higher GLP-1 doses where medication alone can run $349+/month. The program is relatively new (launched November 2025), so long-term reviews and patient outcome data are limited compared to established competitors. There's no behavioral coaching, dietitian access, or lifestyle support beyond clinical medication management — patients wanting comprehensive weight loss support may need to supplement with other services. The lack of compounded options means patients who can't afford or don't qualify for brand-name GLP-1s have no fallback within the platform.
GoodRx for Weight Loss is the best choice for patients who want FDA-approved GLP-1 medications without compounded alternatives and value pharmacy flexibility above all else. The Novo Nordisk partnership pricing is genuinely competitive, and the ability to pick up prescriptions at virtually any pharmacy nationwide is unmatched. However, the subscription-plus-medication pricing model may be cost-prohibitive for some, and the lack of behavioral support means this works best as a clinical medication management service rather than a comprehensive weight loss program.
The subscription costs $119/month (standard price as of February 1, 2026). Medications are priced separately. Wegovy pill: $149/month for 1.5mg and 4mg tablets, $199/month for 9mg and 25mg tablets (discounted through April 15, 2026). Ozempic and Wegovy injections: $199/month introductory price for first two fills at lowest doses (0.25mg and 0.5mg, through March 31, 2026), then $349/month ongoing. Ozempic 2.0mg is $499/month. Zepbound pens available at retail pharmacies; Zepbound vials via home delivery through LillyDirect.
No. GoodRx exclusively prescribes FDA-approved brand-name GLP-1 medications including Ozempic, Wegovy (injectable and oral pill), Zepbound, and Mounjaro. The company has explicitly positioned itself against compounded alternatives, emphasizing safety and proven efficacy of FDA-approved drugs. This is a key differentiator from most telehealth GLP-1 competitors.
FDA-approved GLP-1 medications including Wegovy (semaglutide injection and oral pill), Ozempic (semaglutide injection), and Zepbound (tirzepatide injection and vial). Zepbound pens can be picked up in-store at retail pharmacies; Zepbound vials are available via home delivery through LillyDirect. No compounded medications. Prescriptions can be filled at over 70,000 pharmacies nationwide.
You subscribe to the $119/month telehealth service, then complete a virtual consultation with a licensed healthcare provider who evaluates your eligibility. If appropriate, they prescribe an FDA-approved GLP-1 medication. You fill your prescription at a participating pharmacy using GoodRx discount pricing. Ongoing clinical support includes progress tracking, side effect management, and treatment adjustments.
GoodRx for Weight Loss is designed primarily as a cash-pay option, offering competitive self-pay pricing through manufacturer partnerships. You can use a GoodRx coupon at the pharmacy regardless of insurance status. Insurance coverage for GLP-1s varies by plan and may depend on whether the medication is prescribed for weight loss alone or for conditions like heart disease or sleep apnea. HSA/FSA accounts may be used for both the subscription and medications.
